MADRIGAL PHARMACEUTICALS INC's ticker is MDGL and the CUSIP is 558868105. A total of 142 filers reported holding MADRIGAL PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 1.87 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $340 | -12.6% | 2,327 | +38.3% | 0.03% | -16.1% |
| Q2 2023 | $389 | +0.5% | 1,683 | +5.3% | 0.03% | +10.7% |
| Q1 2023 | $387 | -75.9% | 1,599 | -71.1% | 0.03% | -79.1% |
| Q4 2022 | $1,606 | -99.5% | 5,532 | +21.9% | 0.13% | +396.3% |
| Q3 2022 | $295,000 | +15.2% | 4,538 | +27.1% | 0.03% | +17.4% |
| Q2 2022 | $256,000 | +12.3% | 3,570 | +53.7% | 0.02% | +228.6% |
| Q1 2022 | $228,000 | – | 2,322 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Avoro Capital Advisors LLC | 1,425,000 | $113,701,000 | 1.79% |
| L1 Capital Pty Ltd | 164,860 | $13,154,000 | 1.64% |
| ARMISTICE CAPITAL, LLC | 1,036,000 | $82,662,000 | 1.40% |
| Tao Capital Management LP | 51,396 | $4,101,000 | 1.09% |
| Parkman Healthcare Partners LLC | 31,393 | $2,505,000 | 0.63% |
| Baker Brothers Advisors | 1,499,213 | $119,622,000 | 0.52% |
| Rock Springs Capital Management LP | 262,500 | $20,945,000 | 0.44% |
| ORACLE INVESTMENT MANAGEMENT INC | 38,500 | $3,072,000 | 0.38% |
| Capital Impact Advisors, LLC | 11,775 | $940,000 | 0.37% |
| Hennion & Walsh Asset Management, Inc. | 73,936 | $5,899,000 | 0.31% |